Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes

Ernesto S Nakayasu1, Farooq Syed2, Sarah A Tersey2

  • 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.

Cell Metabolism
|January 14, 2020
PubMed

Insights

Growth/differentiation factor 15 (GDF15) protects against inflammation-induced beta cell death in type 1 diabetes (T1D). Supplementing GDF15 reduced T1D incidence in mice, identifying it as a potential therapeutic target.

Area of Science:

  • Immunology
  • Endocrinology
  • Proteomics

Background:

  • Type 1 diabetes (T1D) involves progressive loss of pancreatic beta cells due to inflammatory cytokine signaling.
  • This signaling disrupts the balance of apoptosis-related proteins within beta cells.

Purpose of the Study:

  • To identify proteins regulated by inflammatory cytokines in human pancreatic islets.
  • To investigate the role of growth/differentiation factor 15 (GDF15) in T1D pathogenesis and its therapeutic potential.

Main Methods:

  • Comprehensive proteomics analysis of human pancreatic islets treated with interleukin-1β and interferon-γ.
  • Functional assays to assess the impact of GDF15 on apoptosis and in vivo efficacy in a mouse model of T1D.

Main Results:

  • Proteomics identified 387 significantly regulated proteins, including repressed GDF15.
  • GDF15 translation was blocked during inflammation and GDF15 was depleted in T1D islets.
  • Exogenous GDF15 inhibited cytokine-induced apoptosis in human islets and reduced diabetes incidence by 53% in NOD mice.

Conclusions:

  • Cytokine-regulated protein networks in human islets were identified.
  • GDF15 is a key protective factor against beta cell apoptosis in T1D and a promising therapeutic target.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
369
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K